Last checked at 11 Nov 2009 18:02
Surgical Innovations Group plc Grant of Options
Surgical Innovations Group plc ("Surgical" or the "Company") announces that the Company has today granted options to subscribe for 3,800,000 ordinary shares of 1p each to directors of the Company (the "New Options"). All of the New Options are exercisable at a price of 1.7p at any time between 11 November 2009 and 11 November 2019.
The New Options granted to the directors of the Company are as follows:
Director Number of New Options granted Douglas Liversidge 400,000 Graham Bowland 2,200,000 Colin Glass 400,000 Ray Simkins 400,000 Professor Michael McMahon 400,000
In addition, the Company announces that the exercise prices of all of the existing options granted to directors, with the exception of the options granted on 27 January 2009 (the "January 2009 Options"), be rebased. As a result the Company has cancelled and reissued 20,000,000 options to the directors of Surgical (the "Rebased Options"). All the Rebased Options are now exercisable at 1.7p at any time between 11 November 2009 and 11 November 2019. The terms of the January 2009 Options are unchanged.
The resulting holdings of options by directors of Surgical are as follows:
Director New Options January 2009 Rebased Options Options Douglas Liversidge 400,000 1,000,000 3,500,000 Graham Bowland 2,200,000 2,000,000 6,000,000 Colin Glass 400,000 1,000,000 3,500,000 Ray Simkins 400,000 1,000,000 3,500,000 Professor Michael 400,000 1,000,000 3,500,000McMahon Enquiries:Surgical Innovations Group plc 07715 612063 Graham Bowland Hanson Westhouse Limited 0113 246 2610
Tim Feather / Matthew Johnson
vendor